A phase 3 clinical trial of ociperlimab for advanced non-small cell lung cancer has been halted after early results showed it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback